UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis

Chest, 2013-09, Vol.144 (3), p.805-812

2013

Link zum Volltext

Verfügbarkeit prüfen

Glutamine Addiction and Therapeutic Strategies in Lung Cancer

International journal of molecular sciences, 2019-01, Vol.20 (2), p.252

2019

Link zum Volltext

Verfügbarkeit prüfen

The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism

Frontiers in oncology, 2019-11, Vol.9, p.1215-1215

2019

Link zum Volltext

Verfügbarkeit prüfen

Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4690

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

The Lancet (British edition), 2009-07, Vol.374 (9685), p.222-228

2009

Link zum Volltext

Verfügbarkeit prüfen

Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5602

2022

Link zum Volltext

Verfügbarkeit prüfen

Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET

EJNMMI research, 2021-01, Vol.11 (1), p.4-4, Article 4

2021

Link zum Volltext

Verfügbarkeit prüfen

Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor

Metabolites, 2021-08, Vol.11 (8), p.537

2021

Link zum Volltext

Verfügbarkeit prüfen

Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review

Metabolites, 2022-06, Vol.12 (6), p.545

2022

Link zum Volltext

Verfügbarkeit prüfen

NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung Cancer

Cancers, 2023-04, Vol.15 (7), p.2127

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care PUlmonary REhabilitation in patients with long COVID: protocol of the PuRe-COVID trial in Belgium

BMJ open, 2023-06, Vol.13 (6), p.e071098-e071098

2023

Link zum Volltext

Verfügbarkeit prüfen

Physical Tests Are Poorly Related to Patient-Reported Outcome Measures during Severe Acute Exacerbations of COPD

Journal of clinical medicine, 2021-12, Vol.11 (1), p.150

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of biomarkers of survival in pulmonary fibrosis

Respiratory research, 2010-06, Vol.11 (1), p.89-89, Article 89

2010

Link zum Volltext

Verfügbarkeit prüfen

Fever and an abnormal chest X-ray during the COVID-19 pandemic

Respiratory medicine case reports, 2020-01, Vol.31, p.101167, Article 101167

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer

Cancer treatment and research communications, 2018, Vol.15, p.7-12

2018

Link zum Volltext

Verfügbarkeit prüfen

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial

Respiratory research, 2009-10, Vol.10 (1), p.101-101, Article 101

2009

Link zum Volltext

Verfügbarkeit prüfen

Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment

Respiratory medicine, 2004-06, Vol.98 (6), p.567-573

2004

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis around the Globe

Seminars in respiratory and critical care medicine, 2017-08, Vol.38 (4), p.393

2017

Link zum Volltext

Verfügbarkeit prüfen

Remote patient monitoring in COVID-19: a critical appraisal

The European respiratory journal, 2022-02, Vol.59 (2), p.2102697

2022

Link zum Volltext

Verfügbarkeit prüfen

HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

The European respiratory journal, 2020-07, Vol.56 (1), p.2001201

2020

Link zum Volltext

Verfügbarkeit prüfen

Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer

Medical physics (Lancaster), 2021-03, Vol.48 (3), p.1226-1238

2021

Link zum Volltext

Verfügbarkeit prüfen

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference

American journal of respiratory and critical care medicine, 2011-12, Vol.184 (12), p.1382-1389

2011

Link zum Volltext

Verfügbarkeit prüfen

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2011-08, Vol.184 (4), p.459-466

2011

Link zum Volltext

Verfügbarkeit prüfen

Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics

Journal of medical Internet research, 2016-07, Vol.18 (7), p.e185-e185

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis

Glutamine Addiction and Therapeutic Strategies in Lung Cancer

The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism

Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics

Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET

Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor

Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review

NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung Cancer

Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care PUlmonary REhabilitation in patients with long COVID: protocol of the PuRe-COVID trial in Belgium

Physical Tests Are Poorly Related to Patient-Reported Outcome Measures during Severe Acute Exacerbations of COPD

Clinical use of biomarkers of survival in pulmonary fibrosis

Fever and an abnormal chest X-ray during the COVID-19 pandemic

Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial

Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment

Sarcoidosis around the Globe

Remote patient monitoring in COVID-19: a critical appraisal

HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics

Suchergebnisse filtern